✦ LIBER ✦

A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer

✍ Scribed by Xin Zhao, Kai Mei, Xiaohong Cai, Jing Chen, Jingrui Yu, Chengya Zhou, Qiu Li

Book ID: 113064486
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 136 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9631-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, multicenter, phase II study

Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Phase II study of liposomal cisplatin (L

Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer

✍ Mylonakis, N.; Athanasiou, A.; Ziras, N.; Angel, J.; Rapti, A.; Lampaki, S.; Pol 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 506 KB

Phase II trial of gemcitabine plus cispl

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer

✍ Yu, Hai-feng; Wu, Feng-qin; Fan, Yun; Lin, Neng-ming; Ma, Sheng-lin; Luo, Lü-hon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 Chinese ⚖ 317 KB

A multicenter, randomized, Phase II stud

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun

A phase II randomized trial of gemcitabi

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

First-line gemcitabine with cisplatin or

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

✍ Wachters, F M; van Putten, J W G; Kramer, H; Erjavec, Z; Eppinga, P; Strijbos, J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB